Current status and perspectives regarding the association between allergic disorders and cancer.
allergy
asthma
atopy
cancer
rhinitis
tumor
Journal
IUBMB life
ISSN: 1521-6551
Titre abrégé: IUBMB Life
Pays: England
ID NLM: 100888706
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
08
01
2020
revised:
05
03
2020
accepted:
19
03
2020
pubmed:
28
5
2020
medline:
16
11
2021
entrez:
28
5
2020
Statut:
ppublish
Résumé
While activation of immune system may lead to a lower risk of some diseases, it has been shown that a history of atopic allergic disorders such as asthma, hay fever, eczema, and food allergies could be related to several types of cancer. However, the evidence is not entirely conclusive. Two proposals suggest a possible mechanism for the association between allergic disorders and cancers: immune surveillance and the antigenic stimulation. The association of allergy and cancer may vary by cancer site and the type of exposure. The aim of current review was to summarize the current knowledge of the association between allergic diseases and the risk of cancers with particular emphasis on case-controls and cohort studies to estimate the cancer risk associated with allergy.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1322-1339Informations de copyright
© 2020 International Union of Biochemistry and Molecular Biology.
Références
Kidd P. Th1/Th2 balance: The hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8:223-246.
Feili-Hariri M, Falkner DH, Morel PA. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: Implications for immunotherapy. J Leukoc Biol. 2005;78:656-664.
Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Díaz PV. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol. Pediatrics. 2006;117:e878-e886.
Matsuzaki J, Tsuji T, Imazeki I, Ikeda H, Nishimura T. Immunosteroid as a regulator for Th1/Th2 balance: Its possible role in autoimmune diseases. Autoimmunity. 2005;38:369-375.
Wang H, Diepgen T. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy. 2005;60:1098-1111.
Chen C, Xu T, Chen J, et al. Allergy and risk of glioma: A meta-analysis. Eur J Neurol. 2011;18:387-395.
Eppel A, Cotterchio M, Gallinger S. Allergies are associated with reduced pancreas cancer risk: A population-based case-control study in Ontario, Canada. Int J Cancer. 2007;121:2241-2245.
Linabery AM, Jurek AM, Duval S, Ross JA. The association between atopy and childhood/adolescent leukemia: A meta-analysis. Am J Epidemiol. 2010;171:749-764.
Turner MC, Chen Y, Krewski D, Ghadirian P, Thun MJ, Calle EE. Cancer mortality among US men and women with asthma and hay fever. Am J Epidemiol. 2005;162:212-221.
Josephs D, Spicer J, Corrigan C, Gould H, Karagiannis S. Epidemiological associations of allergy, IgE and cancer. Clin Exp Allergy. 2013;43:1110-1123.
Turner MC, Chen Y, Krewski D, Ghadirian P. An overview of the association between allergy and cancer. Int J Cancer. 2006;118:3124-3132.
Pagaoa MA, Okcu MF, Bondy ML, Scheurer ME. Associations between vaccination and childhood cancers in Texas regions. J Pediatr. 2011;158:996-1002.
Naugler WE, Karin M. The wolf in sheep's clothing: The role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med. 2008;14:109-119.
Karagiannis SN, Josephs DH, Karagiannis P, et al. Recombinant IgE antibodies for passive immunotherapy of solid tumours: From concept towards clinical application. Cancer Immunol Immunother. 2012;61:1547-1564.
Singer J, Jensen-Jarolim E. IgE-based immunotherapy of cancer: Challenges and chances. Allergy. 2014;69:137-149.
Pardoll D. Does the immune system see tumors as foreign or self? Annu Rev Immunol. 2003;21:807-839.
Suzuki A, Leland P, Joshi BH, Puri RK. Targeting of IL-4 and IL-13 receptors for cancer therapy. Cytokine. 2015;75:79-88.
Nakashima H, Husain SR, Puri RK. IL-13 receptor-directed cancer vaccines and immunotherapy. Immunotherapy. 2012;4:443-451.
Vena JE, Bona JR, Byers TE, Middleton JRE, Swanson MK, Graham S. Allergy-related diseases and cancer: An inverse association. Am J Epidemiol. 1985;122:66-74.
Wen W, Shu XO, Linet MS, et al. Allergic disorders and the risk of childhood acute lymphoblastic leukemia (United States). Cancer Causes Control. 2000;11:303-307.
Cooper GS, Kamel F, Sandler DP, Davey FR, Bloomfield CD. Risk of adult acute leukemia in relation to prior immune-related conditions. Cancer Epidemiol Prev Biomarkers. 1996;5:867-872.
Schüz J, Morgan G, Böhler E, Kaatsch P, Michaelis J. Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer. 2003;105:255-260.
Spector L, Groves F, DeStefano F, et al. Medically recorded allergies and the risk of childhood acute lymphoblastic leukaemia. Eur J Cancer. 2004;40:579-584.
Chang JS, Tsai Y-W, Tsai C-R, Wiemels JL. Allergy and risk of childhood acute lymphoblastic leukemia: A population-based and record-based study. Am J Epidemiol. 2012;176:970-978.
Linet MS, McCaffrey LD, Humphrey RL, et al. Chronic lymphocytic leukemia and acquired disorders affecting the immune system: A case-control study 2. J Natl Cancer Inst. 1986;77:371-378.
Helby J, Bojesen S, Nielsen S, Nordestgaard B. IgE and risk of cancer in 37 747 individuals from the general population. Ann Oncol. 2015;26:1784-1790.
Kasamon YL, de Claro RA, Wang Y, Shen YL, Farrell AT, Pazdur R. FDA approval summary: Nivolumab for the treatment of relapsed or progressive classical Hodgkin lymphoma. Oncologist. 2017;22:585-591.
Cozen W, Hamilton AS, Zhao P, et al. A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma. Blood. 2009;114:4014-4020.
Hollander P, Rostgaard K, Smedby KE, et al. Autoimmune and atopic disorders and risk of classical Hodgkin lymphoma. Am J Epidemiol. 2015;182:624-632.
Melbye M, Smedby KE, Lehtinen T, et al. Atopy and risk of non-Hodgkin lymphoma. J Natl Cancer Inst. 2007;99:158-166.
Koshiol J, Lam TK, Gridley G, Check D, Brown LM, Landgren O. Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States. J Clin Oncol. 2011;29:378-385.
Dikalioti SK, Chang ET, Dessypris N, et al. Allergy-associated symptoms in relation to childhood non-Hodgkin's as contrasted to Hodgkin's lymphomas: A case-control study in Greece and meta-analysis. Eur J Cancer. 2012;48:1860-1866.
Bahrami A, Aledavoud SA, Anvari K, et al. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs. J Cell Physiol. 2017;233:774-786.
Lowcock EC, Cotterchio M, Ahmad N. Association between allergies, asthma, and breast cancer risk among women in Ontario, Canada. Cancer Causes Control. 2013;24:1053-1056.
Hedderson MM, Malone KE, Daling JR, White E. Allergy and risk of breast cancer among young women (United States). Cancer Causes Control. 2003;14:619-626.
Wang H, Rothenbacher D, Löw M, Stegmaier C, Brenner H, Diepgen TL. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer. 2006;119:695-701.
Talbot-Smith A, Fritschi L, Divitini ML, Mallon DF, Knuiman MW. Allergy, atopy, and cancer: A prospective study of the 1981 Busselton cohort. Am J Epidemiol. 2003;157:606-612.
McWhorter WP. Allergy and risk of cancer. A prospective study using NHANESI followup data. Cancer. 1988;62:451-455.
Lariou M-S, Dikalioti SK, Dessypris N, et al. Allergy and risk of acute lymphoblastic leukemia among children: A nationwide case control study in Greece. Cancer Epidemiol. 2013;37:146-151.
Nishi M, Miyake H. A case-control study of non-T cell acute lymphoblastic leukaemia of children in Hokkaido, Japan. J Epidemiol Community Health. 1989;43:352-355.
Ellison-Loschmann L, Benavente Y, Douwes J, et al. Immunoglobulin E levels and risk of lymphoma in a case-control study in Spain. Cancer Epidemiol Prev Biomarkers. 2007;16:1492-1498.
Petridou E, Chavelas C, Dikalioti S, et al. Breast cancer risk in relation to most prevalent IgE specific antibodies: A case control study in Greece. Anticancer Res. 2007;27:1709-1713.
Cheng J, Zens MS, Duell EJ, Perry AE, Chapman MS, Karagas MR. History of allergy and atopic dermatitis in relation to squamous cell and basal cell carcinoma of the skin. Cancer Epidemiol Prev Biomarkers. 2015;24:749-754.
Jo S, Kim TJ, Lee H, et al. Associations between atopic dermatitis and risk of gastric cancer: A nationwide population-based study. Korean J Gastroenterol. 2018;71:38-44.
Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M. History of allergies among adults with glioma and controls. Int J Cancer. 2002;98:609-615.
Shu X, Prochazka M, Lannering B, et al. Atopic conditions and brain tumor risk in children and adolescents-An international case-control study (CEFALO). Ann Oncol. 2014;25:902-908.
Schwartzbaum J, Ding B, Johannesen TB, et al. Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst. 2012;104:1251-1259.
Calboli FC, Cox DG, Buring JE, et al. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst. 2011;103:1588-1595.
Schlehofer B, Blettner M, Preston-Martin S, et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer. 1999;82:155-160.
Ryan P, Lee MW, North JB, McMichael AJ. Risk factors for tumors of the brain and meninges: Results from the Adelaide adult brain tumor study. Int J Cancer. 1992;51:20-27.
Smedby KE, Sampson JN, Turner JJ, et al. Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: The InterLymph non-Hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr. 2014;2014:76-86.
Doody MM, Linet MS, Glass AG, et al. Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control. 1992;3:449-456.
Cartwright R, McKinney P, O'brien C, et al. Non-Hodgkin's lymphoma: Case control epidemiological study in Yorkshire. Leuk Res. 1988;12:81-88.
Cotterchio M, Lowcock E, Hudson TJ, Greenwood C, Gallinger S. Association between allergies and risk of pancreatic cancer. Cancer Epidemiol Prev Biomarkers. 2014;23:469-480.
Olson SH, Orlow I, Simon J, et al. Allergies, variants in IL-4 and IL-4Rα genes, and risk of pancreatic cancer. Cancer Detect Prev. 2007;31:345-351.
Mack TM, Yu MC, Hanisch R, Henderson BE. Pancreas Cancer and smoking, beverage consumption, and past medical history 2. J Natl Cancer Inst. 1986;76:49-60.
De Bueno MH, Maisonneuve P, Moerman C, Runia S, Boyle P. Lifetime consumption of alcoholic beverages, tea and coffee and exocrine carcinoma of the pancreas: A population-based case-control study in The Netherlands. Int J Cancer. 1992;50:514-522.
Rudant J, Orsi L, Menegaux F, et al. Childhood acute leukemia, early common infections, and allergy: The ESCALE study. Am J Epidemiol. 2010;172:1015-1027.
Hughes AM, Lightfoot T, Simpson J, et al. Allergy and risk of childhood leukaemia: Results from the UKCCS. Int J Cancer. 2007;121:819-824.
Brenner AV, Linet MS, Fine HA, et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer. 2002;99:252-259.
Il'yasova D, McCarthy B, Marcello J, et al. Association between glioma and history of allergies, asthma, and eczema: A case-control study with three groups of controls. Cancer Epidemiol Prev Biomarkers. 2009;18:1232-1238.
Schoemaker MJ, Swerdlow AJ, Hepworth SJ, McKinney PA, Van Tongeren M, Muir KR. History of allergies and risk of glioma in adults. Int J Cancer. 2006;119:2165-2172.
Wigertz A, Lönn S, Schwartzbaum J, et al. Allergic conditions and brain tumor risk. Am J Epidemiol. 2007;166:941-950.
Hsiao J-R, Ou C-Y, Lo H-I, et al. Allergies and risk of head and neck cancer: An original study plus meta-analysis. PLoS One. 2013;8:e55138.
Michaud DS, Langevin SM, Eliot M, et al. Allergies and risk of head and neck cancer. Cancer Causes Control. 2012;23:1317-1322.
Brenner AV, Wang Z, Kleinerman RA, et al. Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int J Epidemiol. 2001;30:118-124.
Brownson RC, Alavanja MC. Previous lung disease and lung cancer risk among women (United States). Cancer Causes Control. 2000;11:853-858.
Wu AH, Fontham ET, Reynolds P, et al. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol. 1995;141:1023-1032.
Mayne ST, Buenconsejo J, Janerich DT. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol. 1999;149:13-20.
Rudant J, Orsi L, Monnereau A, et al. Childhood hodgkin's lymphoma, non-hodgkin's lymphoma and factors related to the immune system: The escale study (SFCE). Int J Cancer. 2011;129:2236-2247.
Vajdic CM, Fritschi L, Grulich AE, et al. Atopy, exposure to pesticides and risk of non-Hodgkin lymphoma. Int J Cancer. 2007;120:2271-2274.
Vajdic CM, Falster MO, De Sanjose S, et al. Atopic disease and risk of non-Hodgkin lymphoma: An interlymph pooled analysis. Cancer Res. 2009;69:6482-6489.
Grulich AE, Vajdic CM, Kaldor JM, et al. Birth order, atopy, and risk of non-Hodgkin lymphoma. J Natl Cancer Inst. 2005;97:587-594.
Cozen W, Cerhan JR, Martinez-Maza O, et al. The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk. Cancer Causes Control. 2007;18:821-831.
Silverman D, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer. 1999;80:1830-1837.
Weiss D, El-Zein M, Rousseau M-C, Richard H, Karakiewicz PI, Parent M-É. Asthma, allergy and the risk of prostate cancer: Results from the Montreal PROtEuS study. Cancer Epidemiol. 2014;38:695-699.
Rava M, Czachorowski MJ, Silverman D, et al. Asthma status is associated with decreased risk of aggressive urothelial bladder cancer. Int J Cancer. 2018;142:470-476.
Rosenbaum PF, Buck GM, Brecher ML. Allergy and infectious disease histories and the risk of childhood acute lymphoblastic leukaemia. Paediatr Perinat Epidemiol. 2005;19:152-164.
Engkilde K, Thyssen JP, Menné T, Johansen JD. Association between cancer and contact allergy: A linkage study. BMJ Open. 2011;1:e000084.
Petridou E, Trichopoulos D, Kalapothaki V, et al. The risk profile of childhood leukaemia in Greece: A nationwide case-control study. Br J Cancer. 1997;76:1241-1247.
Hwang CY, Chen YJ, Lin MW, et al. Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: A nationwide cohort study in Taiwan. Int J Cancer. 2012;130:1160-1167.
Petroianu A, Chaves D, De Oliveira O Jr. Comparative incidence of allergy in the presence or absence of cancer. J Int Med Res. 1995;23:358-363.
Johnson LG, Schwartz SM, Malkki A-M, et al. Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster. Cancer Epidemiol Prev Biomarkers. 2011;20:199-207.
Anderson LN, Cotterchio M, Gallinger S. Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada. Cancer Causes Control. 2009;20:825-834.
Gomez-Rubio P, Zock J-P, Rava M, et al. Reduced risk of pancreatic cancer associated with asthma and nasal allergies. Gut. 2015;66:314-322.
Holly EA, Eberle CA, Bracci PM. Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am J Epidemiol. 2003;158:432-441.
Vineis P, Crosignani P, Sacerdote C, et al. Haematopoietic cancer and medical history: A multicentre case control study. J Epidemiol Community Health. 2000;54:431-436.
Briggs NC, Levine RS, Brann EA. Allergies and risk of non-Hodgkin's lymphoma by subtype. Cancer Epidemiol Prev Biomarkers. 2002;11:401-407.
Cho JM, Davis DMR, Wetter DA, Bartley AC, Brewer JD. Association between atopic dermatitis and squamous cell carcinoma: A case-control study. Int J Dermatol. 2018;57:313-316.
Romanet-Manent S, Charpin D, Magnan A, Lanteaume A, Vervloet D. Allergic vs nonallergic asthma: What makes the difference? Allergy. 2002;57:607-613.
Nieves A, Magnan A, Boniface S, et al. Phenotypes of asthma revisited upon the presence of atopy. Respir Med. 2005;99:347-354.
Real FG, Svanes C, Omenaas ER, et al. Lung function, respiratory symptoms, and the menopausal transition. J Allergy Clin Immunol. 2008;121:72-80.e3.
Foschino Barbaro M, Costa V, Resta O, et al. Menopausal asthma: A new biological phenotype? Allergy. 2010;65:1306-1312.
Zemp E, Schikowski T, Dratva J, Schindler C, Probst-Hensch N. Asthma and the menopause: A systematic review and meta-analysis. Maturitas. 2012;73:212-217.
Leynaert B, Sunyer J, Garcia-Esteban R, et al. Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: A population-based cohort. Thorax. 2012;67:625-631.
Davey Smith G, Ebrahim S. ‘Mendelian randomization’: Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1-22.
Jiang X, Dimou NL, Zhu Z, et al. Allergy, asthma, and the risk of breast and prostate cancer: A Mendelian randomization study. Cancer Causes Control. 2020;31:273-282.
Eriksson N, Holmen A, Högstedt B, Mikoczy Z, Hagmar L. A prospective study of cancer incidence in a cohort examined for allergy. Allergy. 1995;50:718-722.
Jensen AO, Svaerke C, Farkas DK, Olesen AB, Kragballe K, Sørensen HT. Atopic dermatitis and risk of skin Cancer. Am J Clin Dermatol. 2012;13:29-36.
Ji J, Shu X, Li X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in hospitalised asthma patients. Br J Cancer. 2009;100:829-833.
Söderberg KC, Hagmar L, Schwartzbaum J, Feychting M. Allergic conditions and risk of hematological malignancies in adults: A cohort study. BMC Public Health. 2004;4:51.
Milan T, Verkasalo P, Kaprio J, Koskenvuo M. Lifestyle differences in twin pairs discordant for basal cell carcinoma of the skin. Br J Dermatol. 2003;149:115-123.
Jacobs EJ, Gapstur SM, Newton CC, Turner MC, Campbell PT. Hay fever and asthma as markers of atopic immune response and risk of colorectal cancer in three large cohort studies. Cancer Epidemiol Prev Biomarkers. 2013;22:661-669.
Prizment AE, Folsom AR, Cerhan JR, Flood A, Ross JA, Anderson KE. History of allergy and reduced incidence of colorectal cancer, Iowa women's health study. Cancer Epidemiol Prev Biomarkers. 2007;16:2357-2362.
Tambe NA, Wilkens LR, Wan P, et al. Atopic allergic conditions and colorectal cancer risk in the multiethnic cohort study. Am J Epidemiol. 2015;181:889-897.
Brown DW, Young KE, Anda RF, Felitti VJ, Giles WH. Re: Asthma and the risk of lung cancer. Findings from the adverse childhood experiences (ACE). Cancer Causes Control. 2006;17:349-350.
Kantor ED, Hsu M, Du M, Signorello LB. Allergies and asthma in relation to cancer risk. Cancer Epidemiol Prev Biomarkers. 2019;28:1395-1403.
Su Y-L, Chou C-L, Rau K-M, Lee CT-C. Asthma and risk of prostate cancer: A population-based case-cohort study in Taiwan. Medicine. 2015;94:e1371.
Mills PK, Beeson WL, Fraser GE, Phillips RL. Allergy and cancer: Organ site-specific results from the Adventist health study. Am J Epidemiol. 1992;136:287-295.
Synnerstad I, Fredrikson M, Ternesten-Bratel A, Rosdahl I. Low risk of melanoma in patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2008;22:1423-1428.
Huang BZ, Le Marchand L, Haiman CA, et al. Atopic allergic conditions and pancreatic cancer risk: Results from the multiethnic cohort study. Int J Cancer. 2018;142:2019-2027.
Gandini S, Lowenfels AB, Jaffee EM, Armstrong TD, Maisonneuve P. Allergies and the risk of pancreatic cancer: A meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Prev Biomarkers. 2005;14:1908-1916.
Olson SH. Selected medical conditions and risk of pancreatic cancer. Mol Carcinog. 2012;51:75-97.
Lindelöf B, Granath F, Tengvall-Linder M, Ekbom A. Allergy and cancer. Allergy. 2005;60:1116-1120.
Rava M, Smit LA, Nadif R. Gene-environment interactions in the study of asthma in the postgenomewide association studies era. Curr Opin Allergy Clin Immunol. 2015;15:70-78.
Ober C, Yao TC. The genetics of asthma and allergic disease: A 21st century perspective. Immunol Rev. 2011;242:10-30.
Cotterchio M, Lowcock E, Bider-Canfield Z, et al. Association between variants in atopy-related immunologic candidate genes and pancreatic cancer risk. PLoS One. 2015;10:e0125273.
Arumugam T, Ramachandran V, Logsdon CD. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst. 2006;98:1806-1818.
Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne colorectal cancer study. Cancer Res. 1988;48:4399-4404.
Negri E, Bosetti C, La Vecchia C, Levi F, Tomei F, Franceschi S. Allergy and other selected diseases and risk of colorectal cancer. Eur J Cancer. 1999;35:1838-1841.
Vojtechova P, Martin RM. The association of atopic diseases with breast, prostate, and colorectal cancers: A meta-analysis. Cancer Causes Control. 2009;20:1091-1105.
Ye W, Chow W, Lagergren J, et al. Risk of adenocarcinomas of the oesophagus and gastric cardia in patients hospitalized for asthma. Br J Cancer. 2001;85:1317-1321.
El-Zein M, Parent M-E, Kâ K, Siemiatycki J, St-Pierre Y, Rousseau M-C. History of asthma or eczema and cancer risk among men: A population-based case-control study in Montreal, Quebec, Canada. Ann Allergy Asthma Immunol. 2010;104:378-384.
Kallen B, Gunnarskog J, Conradson T. Cancer risk in asthmatic subjects selected from hospital discharge registry. Eur Respir J. 1993;6:694-697.
Bosetti C, Talamini R, Franceschi S, Negri E, Giacosa A, La Vecchia C. Allergy and the risk of selected digestive and laryngeal neoplasms. Eur J Cancer Prev. 2004;13:173-176.
Dai Q, Zheng W, Ji B, et al. Prior immunity-related medical conditions and oesophageal cancer risk: A population-based case-control study in Shanghai. Eur J Cancer Prev: Off J Eur Cancer Prev Organ. 1997;6:152-157.
Kita H. Eosinophils: Multifunctional and distinctive properties. Int Arch Allergy Immunol. 2013;161:3-9.
Jensen-Jarolim E, Achatz G, Turner M, et al. AllergoOncology: The role of IgE-mediated allergy in cancer. Allergy. 2008;63:1255-1266.
Prizment AE, Anderson KE, Visvanathan K, Folsom AR. Inverse association of eosinophil count with colorectal cancer incidence: Atherosclerosis risk in communities study. Cancer Epidemiol Prev Biomarkers. 2011;20:1861-1864.
Legrand F, Driss V, Delbeke M, et al. Human eosinophils exert TNF-α and granzyme A-mediated tumoricidal activity toward colon carcinoma cells. J Immunol. 2010;185:7443-7451.
Straumann A, Aceves S, Blanchard C, et al. Pediatric and adult eosinophilic esophagitis: Similarities and differences. Allergy. 2012;67:477-490.
Linos E, Raine T, Alonso A, Michaud D. Atopy and risk of brain tumors: A meta-analysis. J Natl Cancer Inst. 2007;99:1544-1550.
Schwartzbaum J, Jonsson F, Ahlbom A, et al. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer. 2003;106:423-428.
Schlehofer B, Siegmund B, Linseisen J, et al. Primary brain tumours and specific serum immunoglobulin E: A case-control study nested in the European prospective investigation into Cancer and nutrition cohort. Allergy. 2011;66:1434-1441.
Hochberg F, Toniolo P, Cole P. Nonoccupational risk indicators of glioblastoma in adults. J Neurooncol. 1990;8:55-60.
Cicuttini FM, Hurley SF, Forbes A, et al. Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer. 1997;71:203-207.
Schlehofer B, Blettner M, Becker N, Martinsohn C, Wahrendorf J. Medical risk factors and the development of brain tumors. Cancer. 1992;69:2541-2547.
Turner MC, Krewski D, Armstrong BK, et al. Allergy and brain tumors in the INTERPHONE study: Pooled results from Australia, Canada, France, Israel, and New Zealand. Cancer Causes Control. 2013;24:949-960.
Porcelli B, Zoellner NL, Abadin SS, Gutmann DH, Johnson KJ. Associations between allergic conditions and pediatric brain tumors in neurofibromatosis type 1. Fam Cancer. 2016;15:301-308.
Vena JE, Byers TE, Middleton E, Graham S. The authors reply. Am J Epidemiol. 1987;125:540-540.
Alavanja MC, Brownson RC, Boice JD Jr, Hock E. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol. 1992;136:623-632.
Osann KE, Lowery JT, Schell MJ. Small cell lung cancer in women: Risk associated with smoking, prior respiratory disease, and occupation. Lung Cancer. 2000;28:1-10.
Wu AH, Mimi CY, Thomas DC, Pike MC, Henderson BE. Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res. 1988;48:7279-7284.
Osann KE. Lung cancer in women: The importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res. 1991;51:4893-4897.
Huovinen E, Kaprio J, Vesterinen E, Koskenvuo M. Mortality of adults with asthma: A prospective cohort study. Thorax. 1997;52:49-54.
Vesterinen E, Pukkala E, Timonen T, Aromaa A. Cancer incidence among 78 000 asthmatic patients. Int J Epidemiol. 1993;22:976-982.
Boffetta P, Ye W, Boman G, Nyren O. Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden. Eur Respir J. 2002;19:127-133.
El-Zein M, Parent M-E, Siemiatycki J, Rousseau M-C. History of allergic diseases and lung cancer risk. Ann Allergy Asthma Immunol. 2014;112:230-236.
Juan CK, Shen JL, Lin CL, Kim KW, Chen WC. Increased risk of lung cancer in patients with eczema: A nationwide cohort study in Taiwan. J der Dtsch Dermatologischen Ges. 2016;14:924-931.
Qu Y-L, Liu J, Zhang LX, et al. Asthma and the risk of lung cancer: A meta-analysis. Oncotarget. 2017;8:11614.
Karim A, Westenberg L, Eurelings L, Otten R, van Wijk RG. The association between allergic diseases and cancer: A systematic review of the literature. Neth J Med. 2019;77(2):42-66.
Pelaia G, Vatrella A, Maselli R. The potential of biologics for the treatment of asthma. Nat Rev Drug Discov. 2012;11:958-972.
Gramenzi A, Buttino I, D'Avanzo B, Negri E, Franceschi S, La Vecchia C. Medical history and the risk of multiple myeloma. Br J Cancer. 1991;63:769-772.
Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: Roles of reactive oxygen/nitrogen species. J Toxicol Environ Health, Part B. 2008;11:1-15.
Rittmeyer D, Lorentz A. Relationship between allergy and cancer: An overview. Int Arch Allergy Immunol. 2012;159:216-225.
Miller CT, Neutel CI, Nair RC, Marrett LD, Last JM, Collins W. Relative importance of risk factors in bladder carcinogenesis. J Chronic Dis. 1978;31:51-56.
Steineck G, Wiholm BE, De Verdier MG. Acetaminophen, some other drugs, some diseases and the risk of transitional cell carcinoma: A population-based case-control study. Acta Oncol. 1995;34:741-748.
Kim WJ, Lee HL, Lee SC, Kim YT, Kim H. Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis. J Urol. 2000;164:209-213.
Roelofzen JH, Aben KK, Van de Kerkhof PC, Van der Valk PG, Kiemeney LA. Dermatological exposure to coal tar and bladder cancer risk: A case-control study. Urol Oncol: Semin Original Invest. 2015;33:20.e19-20.e22.
Rava M, Czachorowski MJ, Silverman D, et al. Asthma status is associated with decreased risk of aggressive urothelial bladder cancer. Int J Cancer. 2018;142:470-476.
Costello R, O'callaghan T, Sebahoun G. Eosinophils and antitumour response. La Revue de Medecine Interne. 2005;26:479-484.
Huland E, Huland H. Tumor-associated eosinophilia in interleukin-2-treated patients: Evidence of toxic eosinophil degranulation on bladder cancer cells. J Cancer Res Clin Oncol. 1992;118:463-467.
Zacharia B, Sherman P. Atopy, helminths, and cancer. Med Hypotheses. 2003;60:1-5.
Platz EA, Drake CG, Wilson KM, et al. Asthma and risk of lethal prostate cancer in the health professionals follow-up study. Int J Cancer. 2015;137:949-958.
Kazma R, Mefford JA, Cheng I, et al. Association of the innate immunity and inflammation pathway with advanced prostate cancer risk. PLoS One. 2012;7:e51680.
Toriola AT, Laukkanen JA, Kurl S, Nyyssönen K, Ronkainen K, Kauhanen J. Prediagnostic circulating markers of inflammation and risk of prostate cancer. Int J Cancer. 2013;133:2961-2967.
Severi G, Baglietto L, Muller DC, et al. Asthma, asthma medications, and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2010;19(9):2318-2324.
Busillo JM, Cidlowski JA. The five Rs of glucocorticoid action during inflammation: Ready, reinforce, repress, resolve, and restore. Trends Endocrinol Metab. 2013;24:109-119.
Santillan AA, Camargo CA, Colditz GA. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control. 2003;14:327-334.
Severi G, Baglietto L, Muller DC, et al. Asthma, asthma medications, and prostate cancer risk. Cancer Epidemiol Prev Biomarkers. 2010;19:2318-2324.
Xiao-Yan Z, Malloy PJ, Krishnan AV, et al. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med. 2000;6:703.
González-Pérez A, Fernández-Vidaurre C, Rueda A, Rivero E, García Rodríguez LA. Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf. 2006;15:131-138.
Reynolds P, Kaplan GA. Asthma and cancer. Am J Epidemiol. 1987;125:539-540.
Zhu J, Song J, Liu Z, et al. Association between allergic conditions and risk of prostate cancer: A Prisma-compliant systematic review and meta-analysis. Sci Rep. 2016;6:1-12.
Skaaby T, Husemoen LLN, Roswall N, Thuesen BH, Linneberg A. Atopy and development of cancer: A population-based prospective study. J Allergy Clin Immunol Pract. 2014;2:779-785.
Neuchrist C, Kornfehl J, Grasl M, et al. Distribution of immunoglobulins in squamous cell carcinoma of the head and neck. Int Arch Allergy Immunol. 1994;104:97-100.
Liao H-C, Wu S-Y, Ou C-Y, et al. Allergy symptoms, serum total immunoglobulin E, and risk of head and neck cancer. Cancer Causes Control. 2016;27:1105-1115.
Wiemels JL, Wiencke JK, Li Z, Ramos C, Nelson HH, Karagas MR. Risk of squamous cell carcinoma of the skin in relation to IgE: A nested case-control study. Cancer Epidemiol Prev Biomarkers. 2011;20:2377-2383.
Ming ME, Levy R, Hoffstad O, et al. The lack of a relationship between atopic dermatitis and nonmelanoma skin cancers. J Am Acad Dermatol. 2004;50:357-362.
Eriksson N, Mikoczy Z, Hagmar L. Cancer incidence in 13,811 patients skin tested for allergy. J Invest Allergol Clin Immunol. 2005;15:161.
Bahrami A, Hasanzadeh M, ShahidSales S, et al. Clinical significance and prognosis value of Wnt signaling pathway in cervical Cancer. J Cell Biochem. 2017;118:3028-3033.
Montgomery S, Ehlin A, Sparen P, Björkstén B, Ekbom A. Childhood indicators of susceptibility to subsequent cervical cancer. Br J Cancer. 2002;87:989-993.
Wulaningsih W, Holmberg L, Garmo H, et al. Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival. Onco Targets Ther. 2016;5:e1154250.
Kozłowska R, Bożek A, Jarząb J. Association between cancer and allergies. Allergy Asthma Clin Immunol. 2016;12:39.
Sherman PW, Holland E, Sherman JS. Allergies: Their role in cancer prevention. Q Rev Biol. 2008;83:339-362.
Magnan A, Mely L, Prato S, et al. Relationships between natural T cells, atopy, IgE levels, and IL-4 production. Allergy. 2000;55:286-290.
Magnan AO, Mely LG, Camilla CA, et al. Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma: Increased IFN-γ-producing CD8+ T cells in asthma. Am J Respir Crit Care Med. 2000;161:1790-1796.
Naito Y, Saito K, Shiiba K, et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998;58:3491-3494.
Schumacher K, Haensch W, Röefzaad C, Schlag PM. Prognostic significance of activated CD8+ T cell infiltrations within esophageal carcinomas. Cancer Res. 2001;61:3932-3936.
Grossman SA, Ye X, Lesser G, et al. Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. Clin Cancer Res. 2011;17:5473-5480.
Bagnardi V, Rota M, Botteri E, et al. Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis. Br J Cancer. 2015;112:580-593.
Gonzalez-Quintela A, Gude F, Boquete O, et al. Association of alcohol consumption with total serum immunoglobulin E levels and allergic sensitization in an adult population-based survey. Clin Exp Allergy. 2003;33:199-205.
Linneberg A, Petersen J, Nielsen N, et al. The relationship of alcohol consumption to total immunoglobulin E and the development of immunoglobulin E sensitization: The Copenhagen allergy study. Clin Exp Allergy. 2003;33:192-198.
Park S, Kim Y, Shin H-R, et al. Population-attributable causes of cancer in Korea: Obesity and physical inactivity. PLoS One. 2014;9:e90871.
Toskala E, Kennedy DW. Asthma risk factors. Int Forum Allergy Rhinol. 2015;5:S11-S16.
Bergmann RL, Edenharter G, Bergmann KE, Lau S, Wahn U, Group MASR. Socioeconomic status is a risk factor for allergy in parents but not in their children. Clin Exp Allergy. 2000;30:1740-1745.
Boyd C, Zhang-Salomons JY, Groome PA, Mackillop WJ. Associations between community income and cancer survival in Ontario, Canada, and the United States. J Clin Oncol. 1999;17:2244-2244, 2255.
Molet S, Hamid Q, Davoineb F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol. 2001;108:430-438.
Williams HC, Strachan DP, Hay RJ. Childhood eczema: Disease of the advantaged? BMJ. 1994;308:1132-1135.
Van Hemelrijck M, Garmo H, Binda E, et al. Immunoglobulin E and cancer: A meta-analysis and a large Swedish cohort study. Cancer Causes Control. 2010;21:1657-1667.
Jensen-Jarolim E, Bax H, Bianchini R, et al. AllergoOncology-The impact of allergy in oncology: EAACI position paper. Allergy. 2017;72:866-887.